Osteologix Inc. (OTCBB:OLGX) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview on Monday, May 19 at 9:00 a.m. CEST (3:00 a.m. ET) during the Rodman and Renshaw 5th Annual Global Healthcare Conference at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. A live audio webcast and slide presentation will be available via the internet by visiting www.osteologix.com and clicking the link provided under “Latest News”. An archived presentation will be available for 90 days.

About Osteologix

Osteologix is a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, such as osteoporosis, by developing innovative therapies. Its lead investigational product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.

Osteologix Inc.
Investor and Media:
Baxter Phillips, III
Sr. Director, Corporate Development